Progress in the Preclinical Discovery and Clinical Development of Class I and Dual Class I/IV Phosphoinositide 3-Kinase (PI3K) Inhibitors

By  

Current Medicinal Chemistry, Vol. 18, Iss. 18, 2011-06 ,pp. : 2686-2714

Bentham Science Publishers

Access to resources Recommend Favorite

Small Molecule Inhibitors of Phosphoinositide 3-Kinase (PI3K) &dgr; and &ggr;

By  

Current Topics in Medicinal Chemistry, Vol. 9, Iss. 8, 2009-05 ,pp. : 738-753

Bentham Science Publishers

Access to resources Recommend Favorite

Computational Medicinal Chemistry to Design Novel Phosphoinositide 3- Kinase (PI3K) Alpha Inhibitors in View of Cancer

By  

Current Bioactive Compounds, Vol. 10, Iss. 3, 2014-08 ,pp. : 147-157

Bentham Science Publishers

Access to resources Recommend Favorite

The PI3K/Akt Pathway: Recent Progress in the Development of ATP-Competitive and Allosteric Akt Kinase Inhibitors

By  

Current Cancer Drug Targets, Vol. 8, Iss. 1, 2008-02 ,pp. : 7-18

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphoinositide 3-kinase α inhibitors: a patent review

By Denny William A  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 7, 2013-07 ,pp. : 789-799

Informa Healthcare

Access to resources Recommend Favorite